Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | AZN | AMGN | GILD | BMY |
| Company | Spyre Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 77.08 | 183.25 | 336.23 | 132.27 | 56.64 |
| High | 77.08 | 183.44 | 336.23 | 132.80 | 57.11 |
| Low | 72.54 | 180.55 | 325.16 | 129.10 | 56.14 |
| Latest | 74.92 | 181.58 | 326.31 | 129.58 | 57.00 |
| Change | -0.73 | -3.38 | -9.92 | -2.48 | +0.23 |
| % Change | -0.96% | -1.83% | -2.95% | -1.88% | +0.41% |
| Volume | 1,958,700 | 1,379,400 | 3,447,800 | 6,641,000 | 10,824,300 |
| 20-Day Average Volume | 1,124,215 | 2,072,070 | 2,681,700 | 6,230,325 | 10,151,405 |
| Previous Close | 75.65 | 184.96 | 336.23 | 132.06 | 56.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 72.62 | 187.02 | 336.91 | 132.27 | 57.65 |
| 20-Day Raw Stochastic | 66.61% | 6.76% | 15.92% | 17.80% | 29.67% |
| 20-Day Relative Strength | 65.26 | 40.68 | 39.90 | 41.11 | 46.47 |
| Weighted Alpha | +349.35 | +24.31 | +13.99 | +19.85 | +22.00 |
| Today's Opinion | 100% Buy | 24% Sell | 24% Sell | 16% Sell | 8% Buy |
| Previous Opinion | 100% Buy | 16% Sell | 24% Sell | 8% Sell | 8% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.17% since 05/08/26 | -0.69% since 05/08/26 | -1.62% since 05/08/26 | -1.33% since 05/08/26 | +1.50% since 05/08/26 |
| Low | 72.54 on 05/15/26 | 180.55 on 05/15/26 | 325.16 on 05/15/26 | 129.10 on 05/15/26 | 55.40 on 05/11/26 |
| High | 78.80 on 05/11/26 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.10 on 05/15/26 |
| 1-Month | |||||
| %Chg | +8.60% since 04/15/26 | -9.76% since 04/15/26 | -6.29% since 04/15/26 | -7.29% since 04/15/26 | -1.54% since 04/15/26 |
| Low | 66.88 on 04/16/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 78.80 on 05/11/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.26 on 04/16/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +104.53% since 02/13/26 | -11.66% since 02/13/26 | -11.61% since 02/13/26 | -16.39% since 02/13/26 | -6.16% since 02/13/26 |
| Low | 34.96 on 02/17/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 78.80 on 05/11/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +218.81% since 11/14/25 | +1.90% since 11/14/25 | -3.10% since 11/14/25 | +3.65% since 11/14/25 | +22.19% since 11/14/25 |
| Low | 23.01 on 11/21/25 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 78.80 on 05/11/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,569,522 | 286,855,936 | 181,458,304 | 163,961,728 | 115,928,368 |
| Shares Outstanding, K | 86,841 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -155,200,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -69,010,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 3.12 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/05/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/04/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.27 | 15.22 | 15.90 | 9.51 |